• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白内障手术后囊样黄斑水肿的治疗。

Treatment of cystoid macular edema after cataract surgery.

机构信息

From the University Eye Clinic Maastricht (Wielders, Schouten, Aberle, Lambermont, van den Biggelaar, Simons, Nuijts), Maastricht University Medical Center, and the Department of Methodology and Statistics, Maastricht University (Winkens), Maastricht, the Netherlands.

From the University Eye Clinic Maastricht (Wielders, Schouten, Aberle, Lambermont, van den Biggelaar, Simons, Nuijts), Maastricht University Medical Center, and the Department of Methodology and Statistics, Maastricht University (Winkens), Maastricht, the Netherlands.

出版信息

J Cataract Refract Surg. 2017 Feb;43(2):276-284. doi: 10.1016/j.jcrs.2016.06.041.

DOI:10.1016/j.jcrs.2016.06.041
PMID:28366377
Abstract

The purpose of this review was to determine the optimum pharmacologic treatment for cystoid macular edema (CME) after cataract surgery in nondiabetic and diabetic patients. The Cochrane Library, Medline, and Embase databases were searched, and all randomized controlled trials (RCTs) that compared at least 2 pharmacologic strategies for CME after cataract surgery were included. Studies were excluded if preoperative CME or other risk factors for developing CME postoperatively were present. Ten RCTs were included in the systematic review. Five trials included at least 30 participants. Three RCTs showed a greater visual acuity improvement in patients treated with topical nonsteroidal antiinflammatory drugs (NSAIDs) than with a placebo. Other studies comparing the efficacy of topical NSAIDs, topical corticosteroids, sub-Tenon corticosteroids, oral NSAIDs, and oral acetazolamide did not report significant differences between treatment groups. Therefore, large RCTs are needed to provide evidence-based recommendations for the optimum treatment of CME after cataract surgery.

摘要

本综述旨在确定非糖尿病和糖尿病患者白内障手术后囊样黄斑水肿 (CME) 的最佳药物治疗方法。检索了 Cochrane 图书馆、Medline 和 Embase 数据库,并纳入了比较白内障手术后 CME 的至少 2 种药物治疗策略的所有随机对照试验 (RCT)。如果存在术前 CME 或其他术后发生 CME 的风险因素,则排除研究。系统评价纳入了 10 项 RCT。其中 5 项试验至少纳入了 30 名参与者。3 项 RCT 显示,接受局部非甾体抗炎药 (NSAID) 治疗的患者视力改善程度大于安慰剂。其他比较局部 NSAID、局部皮质类固醇、Tenon 下皮质类固醇、口服 NSAID 和口服乙酰唑胺疗效的研究未报告治疗组之间存在显著差异。因此,需要进行大型 RCT 为白内障手术后 CME 的最佳治疗提供循证建议。

相似文献

1
Treatment of cystoid macular edema after cataract surgery.白内障手术后囊样黄斑水肿的治疗。
J Cataract Refract Surg. 2017 Feb;43(2):276-284. doi: 10.1016/j.jcrs.2016.06.041.
2
Prevention of Cystoid Macular Edema After Cataract Surgery in Nondiabetic and Diabetic Patients: A Systematic Review and Meta-Analysis.非糖尿病和糖尿病患者白内障手术后囊样黄斑水肿的预防:一项系统评价和荟萃分析
Am J Ophthalmol. 2015 Nov;160(5):968-981.e33. doi: 10.1016/j.ajo.2015.07.032. Epub 2015 Jul 29.
3
Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane.口服类固醇与局部非甾体抗炎药联合应用对视网膜前膜患者白内障手术后预防黄斑囊样水肿的附加效应
Korean J Ophthalmol. 2017 Oct;31(5):394-401. doi: 10.3341/kjo.2016.0109. Epub 2017 Aug 18.
4
Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment.临床人工晶状体眼黄斑囊样水肿。发生的危险因素及治疗后的持续时间。
J Cataract Refract Surg. 2007 Sep;33(9):1550-8. doi: 10.1016/j.jcrs.2007.05.013.
5
Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review.白内障术后预防炎症和黄斑水肿的甾体和非甾体抗炎滴眼液:系统评价。
Ophthalmology. 2014 Oct;121(10):1915-24. doi: 10.1016/j.ophtha.2014.04.035. Epub 2014 Jun 14.
6
European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.欧洲多中心试验:非糖尿病患者白内障手术后预防囊样黄斑水肿:ESCRS PREMED 研究报告 1。
J Cataract Refract Surg. 2018 Apr;44(4):429-439. doi: 10.1016/j.jcrs.2018.01.029.
7
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.非甾体抗炎药与皮质类固醇药物预防白内障手术后黄斑囊样水肿的疗效及安全性比较。
Int Ophthalmol. 2023 Jan;43(1):271-284. doi: 10.1007/s10792-022-02426-y. Epub 2022 Sep 6.
8
New observation of microcystic macular edema as a mild form of cystoid macular lesions after standard phacoemulsification: Prevalence and risk factors.标准超声乳化术后微囊性黄斑水肿作为一种轻度囊样黄斑病变的新观察:患病率及危险因素
Medicine (Baltimore). 2018 Apr;97(15):e0355. doi: 10.1097/MD.0000000000010355.
9
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery.用于治疗白内障手术后黄斑囊样水肿的非甾体类抗炎药。
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004239. doi: 10.1002/14651858.CD004239.pub2.
10
Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review.白内障手术后囊样黄斑水肿的非甾体类抗炎药:一项系统评价
Br J Ophthalmol. 2005 Nov;89(11):1420-2. doi: 10.1136/bjo.2005.073817.

引用本文的文献

1
Cystoid Macular Edema Following Phacoemulsification and Posterior Chamber Intraocular Lens Surgery: An Aspect From the Past to the Present.白内障超声乳化吸除及后房型人工晶状体植入术后的黄斑囊样水肿:从过去到现在的一个视角
Cureus. 2025 Aug 4;17(8):e89358. doi: 10.7759/cureus.89358. eCollection 2025 Aug.
2
Real-world treatment patterns and economic burden of post-cataract macular edema.真实世界中白内障术后黄斑水肿的治疗模式和经济负担。
BMC Ophthalmol. 2023 Sep 18;23(1):380. doi: 10.1186/s12886-023-03113-x.
3
Safety of the bag-in-the-lens implantation regarding the development of clinically significant pseudophakic cystoid macular edema: A retrospective case series study.
关于袋内透镜植入术引发临床显著的假性囊膜黄斑水肿的安全性:一项回顾性病例系列研究。
PLoS One. 2023 Jan 6;18(1):e0278861. doi: 10.1371/journal.pone.0278861. eCollection 2023.
4
Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.溴芬酸钠 0.09% 治疗非感染性葡萄膜炎继发的黄斑水肿。
Middle East Afr J Ophthalmol. 2021 Sep 25;28(2):98-103. doi: 10.4103/meajo.meajo_134_21. eCollection 2021 Apr-Jun.
5
Safety and Comfort of an Innovative Drug Delivery Device in Healthy Subjects.创新给药装置在健康受试者中的安全性与舒适性
Transl Vis Sci Technol. 2020 Dec 18;9(13):35. doi: 10.1167/tvst.9.13.35. eCollection 2020 Dec.
6
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema.0.3% topical nepafenac在术后黄斑囊样水肿治疗中的疗效
Ther Clin Risk Manag. 2020 Nov 6;16:1067-1074. doi: 10.2147/TCRM.S271184. eCollection 2020.
7
Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome.玻璃体内抗血管内皮生长因子药物的比较及在Irvine-Gass综合征中的治疗结果
Int J Ophthalmol. 2020 Oct 18;13(10):1586-1591. doi: 10.18240/ijo.2020.10.12. eCollection 2020.
8
Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.单纯性白内障手术后炎症的持续存在:6 个月的激光闪烁光度分析。
Adv Ther. 2020 Jul;37(7):3223-3233. doi: 10.1007/s12325-020-01383-1. Epub 2020 May 21.
9
Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.新型曲安奈德载入脂质体局部给药治疗白内障术后囊样黄斑水肿:一项初步研究。
J Ocul Pharmacol Ther. 2019 Mar;35(2):106-115. doi: 10.1089/jop.2018.0101. Epub 2019 Jan 7.
10
Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.预测后发性囊样黄斑水肿对局部皮质类固醇和奈帕芬那治疗反应的因素。
Indian J Ophthalmol. 2018 Jun;66(6):827-830. doi: 10.4103/ijo.IJO_735_17.